Skip to main content
Gustavo Rivero, MD, Oncology, Washington, DC

GustavoAdolfoRiveroMD

Oncology Washington, DC

Physician

Dr. Rivero is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Rivero's full profile

Already have an account?

  • Office

    3800 Reservoir Rd NW
    Washington, DC 20007
    Phone+1 202-444-3736
    Fax+1 202-444-0939

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Cook County Health and Hospitals System
    Cook County Health and Hospitals SystemResidency, Internal Medicine, 2002 - 2005
  • Other
    OtherClass of 1994

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2005 - 2027
  • TX State Medical License
    TX State Medical License 2012 - 2026
  • AZ State Medical License
    AZ State Medical License 2024 - 2025
  • IN State Medical License
    IN State Medical License 2024 - 2025
  • KY State Medical License
    KY State Medical License 2024 - 2025
  • MD State Medical License
    MD State Medical License 2008 - 2025
  • DC State Medical License
    DC State Medical License 2023 - 2024
  • Join now to see all

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Differential Induction Among Younger Patients Diagnosed with Secondary Acute Myelogenous Leukemia Is Feasible By Cytogenetic/Molecular Risk Stratification
    Gustavo A. Rivero, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Superior Outcome in Elderly AML Patients Receiving Adjuvant Serotonin-Reuptake-Inhibitors during Induction
    Gustavo A. Rivero, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Predictive Factors for Complete Remission and Survival in AML Patients Failing to Achieve Adequate Bone Marrow Day 14 Blast Eradication 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Clinical Challenges: Optimizing Infection Prophylaxis in AML
    Clinical Challenges: Optimizing Infection Prophylaxis in AMLSeptember 15th, 2021
  • A Missed Opportunity in Expanded Access Limits Real-World Insights
    A Missed Opportunity in Expanded Access Limits Real-World InsightsJuly 7th, 2020